Expert Explains Why Propofol Was the Wrong -- and Possibly Fatal -- Drug for Michael Jackson
|
| Posted
:
Tue, 07 Jul 2009 04:00:36 GMT |
| Author
:
Barry L. Friedberg |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
American Society of Anesthesiologists' response typical, timid, and tepid, says Dr. Barry Friedberg CORONA DEL MAR, Calif., July 7
CORONA DEL MAR, Calif., July 7 /PRNewswire/ -- Propofol, the chemical name for Diprivan, is formulated for ONLY intravenous use. It is used for general anesthesia or sedation in operating rooms, GI suites, and intensive care units.
Propofol is intended only for use under medical supervision in a medical facility with full heart and breathing monitoring. NEVER for 'at home' use.
Friedberg explains Propofol can kill people just as quickly as it can put them to sleep. Propofol can tell the brain to stop breathing.
According to Friedberg, The American Society of Anesthesiologists' (ASA) response to Jackson's death was typical.
Like the white color of propofol, the ASA July 6th statement/press release continues to be timid by 'white-washing' the probability that deaths like Jackson's would likely be avoided by routine brain monitoring. Dr. Friedberg and other early technology adopters have provided brain monitoring for patients since 1997.
Many patients who come for cosmetic (and other) surgery do not tell their anesthesiologist about ALL the medications or drugs they have been taking.
Lack of this information increases the chances of being overdosed if anesthesia is given without a brain monitor.
"Big Pharma drug profits provide huge sponsorship money to the ASA. Profits decrease if drug sales decrease -- the likely result of the lack of widespread use of brain monitors. How, then, can the ASA claim to represent the patients' best interest by avoiding the risks of routine over medication?" asks Dr. Friedberg. "That's like asking the fox to guard the hen house."
The ASA was also tepid by avoiding mention of propofol abuse within the anesthesia profession, says Dr. Friedberg.
Barry Friedberg, MD, is a practicing, board certified anesthesiologist, author of the textbook, 'Anesthesia in Cosmetic Surgery,' a Congressional award recipient, and an Associate Professor of Anesthesia at the University of California, Irvine.
More information at: www.CosmeticSurgeryAnesthesia.com
SOURCE Barry L. Friedberg
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Cincinnati Thanksgiving Travelers Relax CINCINNATI, OH -- 11/24/09 --
Who
FastPark is an
off-site airport
parking company which operates two facili..
DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years
PITTSBURGH, Nov. 24 /PRNewswire/ --
WHAT: Rom Houbens, a Belgian man thought to have been in coma for 23 years following an auto accident, was actually fully conscious and awake during that time and was the subject of a Good Morning America segment. The DynaVox EyeMax was ...
MCG Capital Corporation to Present at the FBR Capital Markets 2009 Fall Investor Conference on December 2 ARLINGTON, Va. -
MCG Capital Corporation (Nasdaq:MCGC) (“MCG”) announced today that
Steven F. Tunney, MCG's President and Chief Executive Officer, is
scheduled to present a company overview at the FBR Capital Markets 2009
Fall Investor Conference on Wednesday, December 2, 2009 at
PortableApps.com Announces Freeware and Launches Open Portable Software Format
PortableApps.com has announced the finalization of the world's first fully open portable software format allowing users to carry their favorite software on USB flash drives and other devices. Multiple software products from the leading software publishers are now available./I/P
PNew Yo...
Xilinx Announces Upcoming Webcasts With the Financial Community
SAN JOSE, Calif., Nov. 24 -- Xilinx, Inc. (Nasdaq: XLNX) today announced participation in the following upcoming events with the financial community, both of which will be webcast. Interested parties can view the events on Xilinx's Investor Relations website at
Letter of Intent Signed to Form Helios Towers Africa Ltd. with $350 Million of Equity Financing from Global Investor Group LONDON -
A group of investors including Soros Strategic Partners LP, RIT Capital
Partners plc and Lord Rothschild’s family interests, Albright Capital
Management LLC, and funds advised by Helios Investment Partners LLP
announced today the signing of a letter of intent to form Helios To
Brown Family Member to Sell Portion of Nonvoting Brown-Forman Class B Shares LOUISVILLE, Ky. -
Brown-Forman Corporation (NYSE:BFB)(NYSE:BFA) has been notified that Ina
Brown Bond, a Brown family member and former Company director, plans to
direct the sale of up to 1,000,000 shares of the Company’s nonvoting
Class B common stock during the remainder of this cale
|
|
|
|
|
|
|
|
|